Every Second Counts Preventing Irreversible Ischemic Damage – Before it Becomes Permanent IMT-358, a first-in-class metabolic rescue therapy for acute ischemic emergencies. Special Protocol Assessment – Breakthrough Designation – Biological License Application Designation, Phase 3-ready. Program Overview Company The Challenge in Acute Coronary Syndromes Myocardial injury begins within minutes of ischemia Standard therapies restore blood...